Northwest Biotherapeutics’s brain tumour therapy considered for early access in the UK

An experimental cell therapy for brain tumours is the first medicine to be selected for fast-track designation under a new early access scheme in the UK, the Department of Health (DH) announced on 16 September 2014.…